Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-Jae Kim

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Scientific Reports|October 27, 2019
High HDL-C levels reduce the risk of obstructive coronary artery disease in asymptomatic diabetics who achieved optimal glycemic controlGyung-Min Park, Yongjik Lee, Ki-Bum Won, et al.
European Journal of Preventive Cardiology|April 27, 2019
High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individualsYong-Giun Kim, Young-Rak Cho, Gyung-Min Park, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2020
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertensionWoohyeun Kim, Kiyuk Chang, Eun Joo Cho, et al.
Lipids in Health and Disease|January 16, 2020
Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factorsGyung-Min Park, Young-Rak Cho, Ki-Bum Won, et al.
Plos One|April 9, 2020
Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individualsSangwoo Park, Gyung-Min Park, Jinhee Ha, et al.
Clinical Therapeutics|October 10, 2025
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational StudyJae Hyoung Park, Kyung Hoon Cho, Seong-Il Woo, et al.
Diabetes & Metabolism Journal|November 27, 2019
Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography RegistryGyung Min Park, Chang Hoon Lee, Seung Whan Lee, et al.
Journal of Clinical Medicine|August 29, 2024
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCCKyehwan Kim, Moojun Kim, Chang-Ok Seo, et al.
International Journal of Cardiology|May 26, 2017
Prediabetes is not a risk factor for subclinical coronary atherosclerosisGyung-Min Park, Young-Rak Cho, Seung-Whan Lee, et al.
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Scientific Reports|October 27, 2019
High HDL-C levels reduce the risk of obstructive coronary artery disease in asymptomatic diabetics who achieved optimal glycemic controlGyung-Min Park, Yongjik Lee, Ki-Bum Won, et al.
European Journal of Preventive Cardiology|April 27, 2019
High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individualsYong-Giun Kim, Young-Rak Cho, Gyung-Min Park, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2020
A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertensionWoohyeun Kim, Kiyuk Chang, Eun Joo Cho, et al.
Lipids in Health and Disease|January 16, 2020
Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factorsGyung-Min Park, Young-Rak Cho, Ki-Bum Won, et al.
Plos One|April 9, 2020
Homocysteine is not a risk factor for subclinical coronary atherosclerosis in asymptomatic individualsSangwoo Park, Gyung-Min Park, Jinhee Ha, et al.
Clinical Therapeutics|October 10, 2025
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational StudyJae Hyoung Park, Kyung Hoon Cho, Seong-Il Woo, et al.
Diabetes & Metabolism Journal|November 27, 2019
Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography RegistryGyung Min Park, Chang Hoon Lee, Seung Whan Lee, et al.
Journal of Clinical Medicine|August 29, 2024
Clinical Impact of Self-Recognition of Recurrent Acute Myocardial Infarction: From KRMI-RCCKyehwan Kim, Moojun Kim, Chang-Ok Seo, et al.
International Journal of Cardiology|May 26, 2017
Prediabetes is not a risk factor for subclinical coronary atherosclerosisGyung-Min Park, Young-Rak Cho, Seung-Whan Lee, et al.
Clinical Therapeutics|September 10, 2021
A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential HypertensionHae-Young Lee, Kwang-Il Kim, Sang Hyun Ihm, et al.
Pageof 6